China’s State FDA Says Merck Recalled Meningitis Vaccine (China)
This article was originally published in PharmAsia News
Executive Summary
China's State FDA says U.S. drug maker Merck has recalled its Pedvaxhib (haemophilus b) conjugate vaccine for preventing meningitis and other diseases because of a sterilization problem in one of its U.S. factories. Merck said it recalled Pedvaxhib and similar Comvax vaccines after it discovered the sterilization problem in its Pennsylvania factory. No cases of children receiving Hib for preventing meningitis, pneumonia and other infections were reported, although infections usually take at least a week to develop. Hib is combined with a hepatitis B vaccine to prevent the other diseases. (Click here for more